EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunogenicity of PvVir14-derived peptides to improve the serological diagnosis of Plasmodium vivax infection

Ramayana Morais de Medeiros Brito, Raianna F Fantin, Ana Laura Grossi de Oliveira, Ana Rafaela Antunes Porto, Isabela de Brito Duval, José Bryan da Rocha Rihs, Lilian Maria Lapa Montenegro Pimentel, Renata Maria Costa Souza, Elainne Christine de Souza Gomes, Joseli de Oliveira Ferreira, Daniella Castanheira Batholomeu, Ricardo Toshio Fujiwara und 1 weitere

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1484863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Ramayana Morais de Medeiros Brito und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Malaria, Vivax, Plasmodium vivax, Antibodies, Protozoan, Peptides. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Malaria, caused by Plasmodium vivax , remains a major global health problem, particularly in tropical and subtropical regions. This study aimed to investigate the potential of Pv Vir14-derived peptides to improve diagnostic accuracy for P. vivax infections.

Methods

The reactivity of specific Pv Vir14-derived peptides against sera from acutely infected individuals from endemic and non-endemic areas experiencing a P. vivax malaria outbreak was assessed, as well as their sensitivity, specificity, and immunodominance.

Results

Among the eight tested peptides (H08, K09, I03, G08, F08, H04, L06, and N04), H08, G08, and L06 showed significantly higher IgG reactivity in sera from individuals living in endemic areas, mainly within those with multiple malaria episodes. After a P. vivax outbreak in a non-endemic area, H08 and G08 had the highest IgM frequencies, however, sensitivity and specificity analyses indicated that L06 was the most effective peptide for identifying infected individuals. Depletion ELISA confirmed the immunodominance of L06, G08, and H08 and showed a significant reduction in IgG reactivity to Pv Vir14. The peptides L06, G08, and H08, showed high sensitivity and specificity as diagnostic tools for P. vivax malaria.

Conclusions

These peptides can improve diagnostic accuracy, especially in endemic areas, providing better support to malaria control and management programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, VivaxPlasmodium vivaxAntibodies, ProtozoanPeptidesSerologic TestsProtozoan ProteinsAntigens, ProtozoanHumansImmunoglobulin GSensitivity and SpecificityAdultFemaleImmunoglobulin MMaleEnzyme-Linked Immunosorbent AssayYoung AdultMiddle AgedAdolescent

Stichwörter der Autor:innen

MalariaPlasmodium vivaxPvVir14diagnosticsimmunogenicity

Substanzen

Immunoglobulin GAntibodies, ProtozoanPeptidesProtozoan ProteinsAntigens, ProtozoanImmunoglobulin M

Autor:innen und Institutionen

  • Department of Parasitology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Laboratory of Immunobiology and Control of Parasites, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Department of Immunology, Laboratory of Immunoepidemiology of Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil.
  • Department of Parasitology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil.

Zitieren

APA

Brito, R. M. M., Fantin, R. F., Grossi de Oliveira, A. L., Porto, A. R. A., Duval, I. B., Rihs, J. B. D. R., Pimentel, L. M. L. M., Souza, R. M. C., Gomes, E. C. S., Ferreira, J. O., Batholomeu, D. C., Fujiwara, R. T., & Bueno, L. L. (2025). Immunogenicity of PvVir14-derived peptides to improve the serological diagnosis of Plasmodium vivax infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1484863

Vancouver

Brito RMM, Fantin RF, Grossi de Oliveira AL, Porto ARA, Duval IB, Rihs JBDR, et al. Immunogenicity of PvVir14-derived peptides to improve the serological diagnosis of Plasmodium vivax infection. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1484863

BibTeX
@article{Brito2025,
  author = {Brito, Ramayana Morais de Medeiros and Fantin, Raianna F and Grossi de Oliveira, Ana Laura and Porto, Ana Rafaela Antunes and Duval, Isabela de Brito and Rihs, José Bryan da Rocha and Pimentel, Lilian Maria Lapa Montenegro and Souza, Renata Maria Costa and Gomes, Elainne Christine de Souza and Ferreira, Joseli de Oliveira and Batholomeu, Daniella Castanheira and Fujiwara, Ricardo Toshio and Bueno, Lilian Lacerda},
  title = {Immunogenicity of PvVir14-derived peptides to improve the serological diagnosis of Plasmodium vivax infection},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1484863}
}
Kostenlos starten →